Introduction Randomized controlled trials (RCTs) are the gold standard within evidence-based research. Low participant accrual rates, especially of underrepresented groups (e.g., racial-ethnic minorities), may jeopardize clinical studies' viability and strength of findings. Research has begun to unweave clinical trial mechanics, including the roles of clinical research coordinators, to improve trial participation rates. Methods Two semi-structured focus groups were conducted with a purposive sample of 29 clinical research coordinators (CRCs) at consecutive international stroke conferences in 2013 and 2014 to gain in-depth understanding of coordinator-level barriers to racial-ethnic minority recruitment and retention into neurological trials. Coded transcripts were used to create themes to define concepts, identify associations, summarize findings, and posit explanations. Results Barriers related to translation, literacy, family composition, and severity of medical diagnosis were identified. Potential strategies included a focus on developing personal relationships with patients, community and patient education, centralized clinical trial administrative systems, and competency focused training and education for CRCs.
Introduction
Randomized clinical trials advance medical practice by testing the safety and effectiveness of new and established procedures, equipment, and pharmaceuticals [1, 2] . For example, findings from stroke clinical trials have improved patients' quality of life by reducing symptoms and improving functional status [3] . Yet, despite medical advances, low rates of participant accrual can reduce clinical studies' viability and strength of findings [4, 5] .
Historically, low participation rates among racial-ethnic minorities have limited the scientific application of clinical trial findings and, in some instances, have contributed to the failure to detect potential harm when population representation was insufficient to detect negative effects [6, 7] . Furthermore, as medical technology advances to cure complicated diseases, low rates of clinical trial participation by historically underrepresented groups may amplify health disparities [8] . The National Institutes of Health (NIH) sought to ensure the recruitment of women, racial and ethnic minorities, into clinical trials with the adoption of the NIH Revitalization Act of 1993 [9] . Despite the legislation, poor recruitment and retention continue to contribute to the failure and early termination of many clinical trials [6] .
A deep literature describes racial and ethnic minorities' reluctance to participate in clinical research trials [5, 10] . Research findings suggest that patients' mistrust of physicians [11] , research [12, 13] , religiosity [14, 15] , lack of understanding of clinical trials [12, 13, 16] , fear of harm [12, 13] , as well as time, costs, and logistics were the leading barriers that discouraged participation among racial and ethnic minorities [12, 13, 15] . Factors corresponding to study design and implementation have been identified as supporting racial and ethnic minorities' participation including patients' relationship with their doctor, the doctor's reputation, how well the research study is explained, and the extent to which the knowledge gained will benefit others [17] . Although evidence-based strategies to improve recruitment exist (including telephone call reminders, use of culturally sensitive materials) [18] , they are not always deployed [19] . The long-standing recruitment lag among racial and ethnic minorities suggests that the problem has proven complex and somewhat intractable.
Principal investigators (PIs) are ultimately responsible for study recruitment and management. Yet, given limited PI time to participate in lengthy informed consent processes, clinical research coordinators (CRCs) often serve on the front lines of site level recruitment, randomization, retention, data collection, and reporting adverse events [20] . Although the ability of CRCs to influence the patient composition of clinical trials and the potential for selection bias has long been recognized [20] [21] [22] , most research on barriers to clinical trial recruitment has focused on organizational, medical provider, and patientlevel barriers [23, 24] . Despite the considerable influence of CRCs on the composition of clinical trials, relatively little research has been conducted to understand factors that may influence their engagement with patients [20, 25, 26] .
Furthermore, emerging research suggests that interpersonal interactions are perceived to take longer when one participant experiences racial discordance and potential discomfort [27] . Such research, in addition to documented unconscious racial bias in the delivery of medical care services [28, 29] , may have implications for how often and how long study recruiters engage patients from under-represented groups. The current study sought to identify barriers experienced by CRCs when recruiting under-represented populations and to identify potential opportunities to improve representation.
Methods
The National Institute on Minority Health and Health Disparities (NIMHD) and the National Institute of Neurological Disorders and Stroke (NINDS) provided funding for the National Initiative for Minority Involvement in Neurological Clinical Trials (NIMICT), which aims to assist researchers to increase female and racial-ethnic minority participation in neurological clinical trials. NIMICT investigators conducted sequential semi-structured focus groups with a purposive sample of CRCs at the International Stroke Conference in 2013 and 2014 to identify coordinatorlevel barriers to recruitment and CRCs' training needs and to inform the content of a toolkit for research staff. The research questions were as follows:
(1) What barriers do CRCs face in recruiting underrepresented participants to clinical trials? (2) What strategies would be most helpful for improving the recruitment of underrepresented populations?
In preparation for the focus groups, the research team reviewed the literature to identify recruitment challenges and best practices for neurological studies. Researchers opted to emphasize recruitment barriers for the 2013 group and strategies to improve recruitment in 2014. In 2013, two NIMICT researchers (BBA and DFE) facilitated a 90-min focus group. Topics included the following: (1) challenges to integrating NIH Inclusion Policy into trial design and recruitment strategies, (2) distinctive barriers to minority recruitment in stroke/neurological trials, and (3) identification of best practices to enhance minority involvement through improved communication. In 2014, two NIMICT researchers facilitated a 120-min focus group and topics included the following: (1) information-seeking behaviors among CRCs including barriers identified in the previous year; (2) use of available tools and resources; and (3) requested tools, resources, and services to recruit and retain clinical trial participants with particular attention to resources needed for racial-ethnic minority and underserved populations. Prior to beginning each focus group, participants were informed that the discussions would be recorded for academic research purposes and that the results may be published. Anonymity was guaranteed and participants had the option to withdraw from the discussion at any time. The New York University's Committee on Activities Involving Human Subjects (UCAIHS) approved the study.
Analysis
All focus group sessions were audiotaped and transcribed verbatim by trained professional staff. In addition to audio recordings, NIMICT staff used field notes to document the characteristics of the groups' conversation, including participants' tone and non-verbal responses. The study used a deductive framework analysis [30, 31] . The six stages of framework analysis (familiarization, identifying a thematic framework, indexing, charting, mapping, and interpretation) are well suited for applied analysis as they allow researchers to use existing conceptual models and theories to describe and interpret processes within a given setting [31] . After repeated readings, transcripts were coded by two authors (SJH and JR). Coded passages across all transcripts were then placed into separate charts according to identified themes. Coded charts were independently reviewed by two authors (LES, NSP) for consistency and agreement. Continuous chart and transcript reviews were used to further define concepts, identify associations, summarize findings, and posit explanations in the mapping stage.
The study used the leadership framework developed by Heifitz and Laurie to identify technical and adaptive strategies that can address barriers to enrollment [32] . Heifitz and Laurie describe adaptive problems as systemic with no ready answers. Adaptive strategies are those that engage the collective intelligence of employees at all levels and cause some discomfort. In contrast, technical problems are those that may be solved by reengineering with little input or participation from those who do the work.
Results
A total of 17 CRCs participated in the 2013 focus group and 12 participated in 2014. Participants in 2013 were mostly female (88%) and 47% had nursing backgrounds, including BSN, CRNP, CNRN, and RN credentials. Nearly a quarter (24%) held specialized clinical research credentials (e.g., CCRA, CCRC, and CCRP). Participants in 2014 were similar (85% were female; 50% had backgrounds in nursing and 23% held specialized clinical research credentials). All CRC participants recruited patients for clinical trials from hospital settings. Most participants had significant experience working on clinical research studies, with an average of 12 and 11 years of experience in the 2013 and 2014 groups, respectively. Four individuals participated in both focus groups (Table 1) . CRCs identified both administrative and patient impediments to recruitment of underrepresented participants to clinical trials. Administrative barriers included limited translation services and job training that were not titrated to employee's needs. Patient-level barriers included poverty, literacy, family composition, and perceived seriousness of the medical condition. In addition, participants identified the historical legacy of racialized clinical trials as a consistent barrier to patients' participation.
Barrier: Role of Translation
Several CRCs reported narrow eligibility time constraints imposed by study protocols. CRCs stated that time constraints sometimes influenced which patients were approached and how rigorously patients were engaged. Acute trials that enrolled patients within hours of an index event were particularly susceptible to such sorting. For example, having a first language other than English was seen as a barrier by some CRCs where the need for translation was an impediment to meet time thresholds: …you won't be able to spend days with a patient, and I have found that in those situations, because it is a very long process, it takes twice as long because it is being spoken twice…. The need for translation also raised fidelity concerns about the appropriateness of translating scales into many languages, even when translation services were readily available.
I also don't know if the scales that I'm using are even translatable. If I'm doing a cognitive scale, can I just translate that literally, and does that still work? I don't know the answers to those questions. That's what makes it very difficult when you are looking at minority In this instance, the participant raised a central concern related to whether instruments retain their validity when translated as recruitment extends to diverse participant pools.
Barrier: Patient Literacy
Translation concerns were not the only language-related barrier. CRCs discussed ways in which patients' low literacy levels served as a deterrent to recruitment, especially as informed consent processes have grown more complicated. CRCs highlighted concerns about participants' ability to meet IRBs' comprehension standards.
We don't have this problem with minorities per se, but we have a lot of issues with education. We have a population of Caucasians with low education. (2013 participant)
For some, the need to repeat explanations for a participant to attain necessary comprehension thresholds for informed consent imposed considerable recruitment barriers.
Barrier: Family Composition
Time constraints were also identified as a potential barrier for enrollment of participants with different family compositions. One CRC offered: I would say I have a lot of interactions with Hispanics because they want to get their entire family together. You tell it to one daughter who is the primary decision maker, but that daughter also wants the other daughters to know. CRCs suggested that the size composition of a family can add time to the recruitment process, which was especially concerning during acute trials. In addition, the identification of the family as a Bvery large white family^may be intended to reinforce a sense, perhaps an expectation, of colorblindness among CRC participants. … I don't think about their race or ethnicity, I just think that they are eligible, so I kinda go that way. We have pretty good success because we are looking at eligibility and we want our numbers to be high. I don't care what color they are, honestly. (2013 participant).
Participants did not perceive race and ethnicity as a barrier. In fact, the participants above insisted that neither played a role in trial recruitment, despite extensive evidence of a historically racialized medical delivery system [33, 34] . Even as racial and ethnic differences were downplayed, CRCs' perception of the influence of other patient characteristics was complex and varied. Although most CRCs denied that race played a role in their approach to recruitment, members of the 2014 focus group relied on other (poverty, literacy, and language) factors when deciding to engage a potential participant. Even as CRCs' perceptions of a patient's ability to consent and comply with study requirements appeared to influence their motivation to actively recruit patients, some attempted to transcend initial impressions to offer participation to anyone who was eligible. For example, a 2014 participant suggested that: BEven though I have a feeling that you are not going to do well, I still need to at least try to put you in the study.^Another participant reflected on the experience of Botherness,^and CRCs' role.
If you're going to enroll a population that feels in any way 'other' to you personally, it takes a little more effort and if you're not proactive in being prepared to do that and really working toward that before it occurs, you are more likely to either inadvertently or deliberately miss that deadline and timeline. And that will result in a lower enrollment than you should have reflecting the population that you have the opportunity to work with. (2013 participant)
This passage was one of the two in the transcripts that raised the specter of implicit bias [28] , although the speaker was careful not to identify race or ethnicity explicitly or to suggest that such biases could be in any way intentional or structural. The participant's use of Botherâ ppears to imply a myriad of diverse patient characteristics, even as it avoids making those differences explicit.
Barriers: Historical Legacy
Although several CRCs moderated the role that race and ethnicity played in their recruitment, CRCs' repeatedly described under-represented patients' distrust of research, specifically clinical trials. In the shadow of the Tuskegee Syphilis study [35] , concerns often took the form of patients' lack of trust in medical research. A participant offered a personal experience:
One is about 4 years ago, [I] had a [research study acronym] patient's wife say BI know all about Tuskegee, we are not going into the study.^(2013 participant)
The legacy of the Tuskegee Syphilis study [35] , in combination with other racialized epidemiological and medical events, may contribute to a sense of research skepticism among potential study recruits. One CRC discussed the ramifications of underrepresented groups' medical marginalization and connected those historical reverberations with patients' hospitalization experiences during a serious medical event.
I don't think it's a Hispanic or a Black problem. I think it's a problem of how they have developed in their family, church, and community, and what type of medical care they have had in normal circumstances before they end up in the ICU, incapacitated with a family that is scared to death that their loved one is going to die within the next four hours. (2013 participant)
More than one participant suggested that CRCs may anticipate this lack of trust and either avoid or engage racial and ethnic minority patients differently.
Sometimes, I think we are afraid, especially white people, are afraid to approach minorities. I really do.
I wonder if we are afraid and so if you are afraid, then you go into the situation, do you think that patient does not know that you are just funky? (2013 participant)
Barrier: Serious Medical Condition and Grief
Several CRCs raised recruitment concerns related to patients' grief. Approaching a patient with a serious medical condition or a patient whose family was grieving was identified as a barrier.
I work in the ICU with ICH patients, many of which are very, very ill. And it is a challenge. Sometimes I get those patients when, 24 hours, these patients are not going to make it. It is weird because you are pursuing someone who you know is not going to make it. (2013 participant)
As such, some of the CRCs expressed hesitation to engage when they perceived patients to have little time remaining.
Barrier: Hiring and Training
Participants identified workforce issues, including the young age at which CRCs are often hired, their short tenures, relative independence, lack of on-going support, and their inexperience with serious illness and loss. Identification of these constraints led to a discussion of the need for better, standardized CRC training, especially among newly hired CRCs. Given less than robust training, a CRC wondered if the culmination of repeated recruitment denials manifested such that a CRC's anticipation of an impending denial become a self-fulfilling prophecy.
I wasn't smart enough about my protocols and consenting process to be able to convey the security that that person needed. So you get denied. Then subconsciously, you think you will just not go there because you are tired of getting denied. And so then, my PI would say to me, what's your deal? Why are you not enrolling these patients? Because at the end of the day, it's if this patient meets criteria, why aren't they involved? (2014 participant)
Even as CRCs identified multiple barriers (e.g., insufficient training, translation and literacy requirements, patient severity), they also offered recommendations to improve recruitment efforts.
Research Question
CRCs' recommendations to improve recruitment of underrepresented groups focused on study preparation, patient education, community outreach, site education, and the need for enhanced recruitment and training of study staff.
Strategy: Advanced Preparation
CRCs underscored the need to conduct rigorous advanced planning to improve recruitment efforts among the underserved, including beta testing of recruitment scripts and consent forms to anticipate cultural pitfalls, simplifying complicated medical concepts, and streamlining the informed consent process. One 2014 respondent recommended developing a short multi-language overview of the study to gauge nonEnglish speakers' interest in participation before summoning translators. The respondent suggested that a brief written introduction could conserve translators' time and help to assure appropriate resource deployment.
Strategy: Leveraging Translation
Although several CRCs were concerned about the time required for translation during acute trials and whether the translation preserved validity, one CRC framed translation as an opportunity to more strongly engage. When time was not such a factor and where a facility served large numbers of people whose first language was not English, the institution tended to have the necessary infrastructure, including written resources and interpreter services to recruit under-represented populations. In these instances, when a facility was accustomed to servicing a particular linguistic need, the interpretation services appeared seamlessly integrated into the workflow and the additional time in translation was considered an opportunity to build stronger relationships with potential participants to improve recruitment rates.
I feel like these patients benefit from enrolling in a trial because they have someone who sits down with them and spends, over the course of a day or two, hours with a translator explaining consent and then answering other medical questions they have about what's going on. (2013 participant)
Strategy: Patient Education
CRCs frequently mentioned the need to develop recruitment language that carefully and authentically explained the study and reassured prospective participants. For example, one 2013 participant explained that their institution's investigators explored the use of recruitment language used at their site. They discovered that their patients tended to perceive the term Brandomization^as binary-where the available options meant that a patient could either receive the Bgood( successful) treatment or something that was not effective. Instead, the CRC suggested replacing Brandomization^with the use of metaphoric language that compared study assignment to Bhaving a baby, it's [either] a boy or a girl, 50/50^to convey that both options are equally good. (2013 participant)
Another recommendation was to identify the federal funding source during the introduction of the study to underscore the importance of the study's scientific merit. However, the respondent added that privacy assurances must follow such funding attributions. In keeping, some participants asserted the need to reassure under-represented patients that they were not being recruited because of their race, ethnicity, or gender, but because they fit the study's specific enrollment criteria. Similarly, a participant described the importance of sharing detailed study protocols procedures with patients and family members, including assurances that patients will receive high quality care (not an alternative, sub-standard version), regardless of whether or not they enroll or terminate early, as well as information about how the study aligns with their providers' care plan. The participant suggested that such detail often reduced patients' concerns about being used as a Bguinea pig.^(2013 participant)
One participant described the process of patient education as a vehicle to enhance trust to ultimately improve recruitment: Bpatient education is key because then you are gaining trust immediately.^(2013 participant) The participant described the need to educate potential participants about both the study and the disease, observing that many patients are not able to fully absorb all relevant information about their condition during their initial physician consultation: B…before I even talk to the patient or a family about the study, I talk to them about the disease.^(2013 participant) Participants also discussed the types of materials that advanced patients' education. Participants suggested that using a well-organized informational packet, a dedicated website, and online videos to meet patients' different learning styles were helpful to address patients' and family members' questions once they left the hospital. (2014 participant) Pamphlets that defined Bplacebo,B clinical trial,^and Binformed consent^also seemed to aide recruitment efforts, especially when they included customized information for various populations.
Strategy: Community Outreach
As an extension of the need to educate individual patients, one CRC discussed a macro approach to improve study participation, whereby team members conducted information sessions at community centers about clinical trials generally and about their particular study. Another participant emphasized the importance of having strong community relationships and focused on the need for PI's to have sufficient community connections, networks, and willingness to deliver a diverse clinical trial population if that was the expectation of the funding source.
If you want to look at including a larger range or different populations in trials as a whole, you need to develop PIs that are really aggressively going to work at building this also…. (2014 participant)
Strategy: Personal Relationships with Patients
Most participants agreed that personal communication was a core patient engagement strategy: BI still feel like a personal connection is the strongest way.^(2014 participant) As a specific relationship building strategy, one participant suggested that language akin to Bwe want to partner with you and be partners in this research so that we can really find an answerŵ as helpful to establish the sense of trust that is often missing in such encounters. (2013 participant) Others suggested that asking whether a patient liked to Bhelp others^could prove successful to recruitment efforts. Some coordinators suggested that allowing patients to use BFaceTime^(Apple iphone technology) to access PIs when patients had questions could be beneficial to extend interpersonal connections.
Participants emphasized different strategies to enhance the patient-CRC connection. Some emphasized the value of creating authentic communication to establish that B… you care about them and you are conveying that, and you are honest with them….^(2013 participant), while other CRCs focused on their ability to assure quality treatment: BI hope that they get whatever group that they want to be in. But my job as a coordinator is to keep an extra set of eyes on them…^(2013 participant) Several participants expanded the conversation about the importance of fostering relationships to include hospital staff.
Strategy: Relationships with Hospital Staff
Akin to the recommendations to build relationships with patients, participants called on study staff to develop strong relationships with hospital staff, especially nurses, to improve patient recruitment.
What the patient or what the family is going to do after you leave is that they are going to say to the nurse, BWhat do you think about that?^And unless you build that relationship, the nurses are not going to be able to support. (2014 participant) Some participants identified specific strategies to enhance recruitment such as the need to introduce oneself often, describe study content, to remind hospital staff about the various studies regularly, and to provide monthly recruitment feedback (number patients screened, enrolled, etc.). Some described using posters and white boards where nursing staff congregated to highlight ongoing studies and study contact information-including pager numbers. Given that one institution can host multiple studies at any given time, CRCs are often in competition for staff members' attention. Participants underscored the need to remind staff often about study opportunities: BYou have to go all the time. Talk to them, remind them about studies.^(2014 participant) Some participants were able to use monthly meetings with hospital staff to follow up on recruitment progress and to reconcile the number of eligible patients, contacts made, and patients enrolled. Others made consent forms available throughout the hospital to facilitate recruitment.
Strategy: Staff Training
Participants offered several suggestions to improve CRCs' training, especially for new employees. Participants talked about the time required to learn what patients need in order to feel safe to participate. Several described the value of having more seasoned CRCs available to answer questions from newer CRCs.
There should be something that you can always look at or talk to somebody who has done this for a long time and say, BLook, here are a few things you may want to know.^(2014 participant) One suggestion that did not gain much traction was to establish a telephone Bhotline^for staff; participants thought that as health service professionals, they should know the content of their studies. Alternatively, the suggestion that senior coordinators Bshadow^more junior coordinators during early patient interactions elicited positive feedback. It was also recommended that new CRCs receive training on research study implementation protocols so that they are clear about study functions and where to turn for questions. (2014 participant) BBest practice^guides were recommended for all CRCs, but especially during the Bon-boarding^process of new hires. However, training-related conference calls and webinars were perceived as less helpful for seasoned staff. Even as participants identified a number of helpful organizational and personnel strategies to improve recruitment efforts, neither the need for cultural sensitivity training [36, 37] nor the improved competencies related to engaging patients of different backgrounds were identified.
Strategy: Staff Hiring
The training discussion quickly segued into a conversation about hiring requirements and the importance of identifying CRC competencies that include those for novice, intermediate, and expert CRCs.
I think it's a great idea…how to hire a coordinator who will be effective at recruitment. How many times has everyone heard a PM or PI say BI really dropped the ball on that person^? (2014 participant) Discussion CRC focus group participants identified a myriad of challenges when they attempt to recruit patients for neurological trials. Much of the focus groups' conversations about recruitment barriers and strategies centered on securing informed consent. Barriers included translation, literacy, family composition, patients' demographics, symptom severity, and the social legacy related to disparate racial treatment in medical research studies. CRCs also identified numerous recommendations to improve study recruitment including the need for advanced preparation, patient education, community education, relationship building with patients and hospital staff, and improved CRC hiring using recommended competency assessments and training. Potential adaptive and technical solutions that align with identified barriers and strategies are offered below (also see Table 2 ).
Study participants emphasized the importance of informing hospital staff about clinical studies and used a variety of education strategies. Some of the approaches were personality dependent (tenacity and charisma were valued character traits), but many were pragmatic, including the use of white boards where nursing staff gathered to list studies and contact information, regular reminders about study eligibility, and recruitment updates. An adaptive approach would systemize all clinical trial eligibility standards across institutions and make operational units (and their staff) partially responsible for patient recruitment rather than place the full responsibility on individual CRCs. An institution-wide clinical trial recruitment PI responsible to assure all CRCs achieve prescribed competencies, including cultural competency process could reduce the vagaries of personality required to develop individual relationships for each clinical trial, staff member by staff member. CRCs repeatedly identified the emotional challenges associated with having to request participation from seriously ill patients. The difficulty of such recruitment has been documented by prior literature [38] . CRCs requested additional support to help them cope with the daily emotional demands of their engagement with seriously ill patients. Participants also recommended enhanced training for new CRCs to help them engage patients, including the need for training materials to be available in multiple formats, shadowing of recently hired CRCs by senior staff, ongoing technical assistance, and competency measures aligned with novice, intermediate, and expert CRC roles. These focus group recommendations are consistent with a growing call for the consolidation of clinical trial functions and the adoption of standardized, competency-focused training for all clinical trial recruiters [39, 40] . A technical strategy to improve recruitment might require individual PIs to certify CRCs' competencies, including cultural competence [36] .
Although frequently identified as a barrier, translation did not seem to manifest universally as a challenge. Sites that lacked racial and ethnic diversity or whose translation infrastructure was insufficient to support on demand service requests experienced the most challenges. One recommendation was to create a brief, multi-language study introduction to assess patients' initial interest before translators are summoned. However, where translation capacity appeared sufficient, participants were cautious about widespread adoption as some participants relied on the help of in-person translators to build trust with patients who may already be alienated from US healthcare services and suspicious of medical care research. Using an adaptive approach to problem solving, those hiring CRCs would prioritize bilingual staff in diverse catchment areas to maximize opportunities for relationship building during the introduction phase. Such an adaptive approach to translation would take time to assure a sufficiently trained bilingual workforce. Technical approaches might rely on translation call centers and the use of handheld technology.
Literacy concerns transcended nativity, racial, and ethnic categories as did concerns related to family composition. Literacy challenges were an especially serious concern when consent processes required participants to respond in a short period of time or reach predetermined comprehension thresholds. Concerns about patients' literacy and their ability to manage their health conditions have been longstanding [41] . Adaptive approaches to literacy concerns include having hospital staffs assess all patients' comprehension about their health issue immediately after diagnosis to improve treatment adherence, educating patients and families about clinical research studies a priori, including commonly used research language and expanding the unit of recruitment from the individual to the family. Technical approaches would require that all materials be brief and meet national literacy recommendations [42] .
Although CRCs generally downplayed the role that race and ethnicity played in their recruitment efforts, it is worth noting that they readily described the challenges presented by patients' other demographic features including literacy, the need for translation, and poverty. When specifically queried about whether race affected their recruiting, several participants were strident that it did not. However, when asked what got in the way of participation by under-represented groups, CRCs quickly identified distrust of medical studies and referenced Tuskegee. In part, the reluctance to discuss race may have to do with the sensitivity of the topic. CRCs were more willing to talk about the impact of poverty, translation, family size, and patients' medical severity on their recruitment efforts than about race. The reluctance of medical staff to discuss the influence of race and ethnicity has been documented in other studies [33, 43] .
In addition, participants' general reluctance to discuss race and ethnicity does not attenuate their recognition of differences. In fact, participants remained keenly aware of patients' differences. Whether to indicate economic standing (Btoo poor to participate^), or even differences related to severity of illness (Bthese patients are not going to make it^), language invoking participants' Botherness^appeared sporadically throughout the transcripts. Participants invoked such differences to indicate extremes, as in the example above with very sick patients, or to insinuate sameness, as when participants suggested that literacy concerns were not a Bblack thing( suggesting that they were also a Bwhite thing^) [44] . While an in-depth analysis of the theoretical underpinnings of difference is beyond the scope of this study, it is worth noting that such binaries are often imbued with a power differential [44] . Given the institutional legacy of racialized healthcare services and medical research, more investigation into CRC's perception of difference is warranted [36, 37] .
Participants suggested that patients often do not fully retain the intricacies of their providers' communication at the time of their diagnosis [45] . Participants further described the need for simplified (non-technical) study language to encourage authenticity as a prerequisite to recruiting participants. Widespread documentation concerning a lack of health literacy across populations supports simplification of clinical trial language [46, 47] . For example, assignment language that avoids the win/lose juxtaposition of Brandomization,^such as the use of metaphor to convey diagnosis information and treatment options simply and directly can also enhance trust between CRCs and potential participants [48] .
Most of the strategies recommended by CRCs focused on the accessibility of study language to potential participants, enhancing the training of CRCs, the importance of building relationships across hospital staff, and other strategies consistent with the role of CRCs and study implementation. Fewer strategies focused on study purpose and design, including the role that patients' physicians play in transferring information and trust to the study team, the PI's reputation, or how likely results from the study will benefit others [17] .
An adaptive problem focused framework would have the host institution assure that the research is important to the community and understandable, not just scientifically novel. It will also necessitate a deeper connection between study priorities and underrepresented communities to more closely align with the patients they serve, increase transparency of study procedures, and goals, including visible, consistent, and meaningful community outreach by the host institution that transcends clinical trial or study recruitment. For example, given the description of barriers related to patients' identification of a legacy of racialized medical research studies, a few participants recommended that study staffs, especially physicians, provide education in under-represented settings to explain clinical trials generally and then particular study aims. Similarly, one suggestion was to explicitly assess the ability of the PI to engage under-represented communities during the review process before funding decisions were made.
Internal Revenue Service requirements now mandate that hospitals conduct community needs assessments to maintain their non-profit 501(c)(3) tax exempt status [49] . These requirements might be leveraged by state health departments to support deeper community engagement from hospitals. For example, state and local health departments from Rhode Island to California have created and staffed health equity units to improve residents' health status within and across communities [50, 51] . Many of these units already conduct or support community-based health assessments, and a pairing of efforts between academic medical settings and government public health offices might advance both public health and clinical research priorities within communities. On the technical side, institutional review boards might require intensive training of the clinical trial workforce to examine and challenge CRCs' potential discomfort or biases [52, 53] .
Although it is reasonable to expect that an additive effect may operate, whereby the presence of more than one barrier (e.g., need for translation, large family involvement, literacy concerns) might compound CRCs' reluctance to engage a patient, it is unclear from this study what, if any, those interactions might be. Although four CRCs participated in both focus groups, 2014 participants heard a summary of barriers identified by the 2013 group; they did not develop their own set. As such, there may have been some variations in the identified barriers between years. In addition, CRC participants were not asked to identify their race, ethnicity, or language capacities. CRCs were also not sorted by their years of experience or assessed for their ability to recruit participants from underrepresented groups. Furthermore, this preliminary study can only identify themes as participants were not asked to rank barriers by either intensity or frequency. Future research may be warranted to identify CRCs who are highly effective in recruiting underrepresented populations to identify strategies that are most effective. In addition, recruitment strategies might be compared to determine relative effectiveness.
Other limitations in this study are consistent with standard qualitative methodological practice. Although the authors maintained sensitivity during data analysis to ways in which power relationships informed participants' responses, the authors were not themselves CRCs. In addition, participants were recruited from neurological conferences and, as such, may not be representative of all CRCs. In turn, any conclusions may not apply to research recruiting for other health conditions and diseases.
Conclusion
Future research to improve the recruitment of underrepresented populations should focus on the role of the medical center within the community; the PI, including her/his ability to enroll underrepresented groups [54] ; the process of developing scripts that are short, simple, clear, and authentic; the availability of on-demand translation services and delivery mechanisms (in person, in writing, or video format); and enhanced CRC training to support patient initiation and study engagement. Several other authors have begun to call for adaptive changes in study design [1] , training and recruitment of CRCs, and the use of competency-based hiring and training [40, 54] . In addition, research that focuses on what situations CRCs avoid, in addition to what they do and how they do it, and strategies to help them better engage is needed to better understand recruitment deficits among racial and ethnic minorities, especially where disease prevalence is compelling.
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